1. Гендон Ю.З. Свиной грипп H1N1/Калифорния – страсти и факты. Журн. микробиол. 2010; 4: 105–114.

2. Peters G. Swine Flu (H1N1/09). An Interim Assessment. Dtsch. Arztebl. Int. 2009; 106 (47): 769.

3. Опыт применения осельтамивира при пандемии гриппа 2009 года (ред.). Клин. фармакол. и тер. 2009; 5: 5–9.

4. Яцышина С.Б., Миненко А.Н., Кушакова Т.Е. и др. Пандемический грипп А/H1N1(sw2009) в России: эпидемиология, диагностика, клиническая картина и лечение. Тер. арх. 2010; 11: 10–14.

5. Климова Е.А., Ющук Н.Д., Кареткина Г.Н. и др. Исходы тяжелого течения пандемического гриппа А /H1N1/ 2009. Тер. арх. 2010; 11: 15–18.

6. Morgan O.W., Bramley A., Fowlkes A. et al. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A (H1N1) disease. PLoS One 2010; 5 (3): e9694.

7. Hanslik T., Boelle P.5Y., Flahault A. Preliminary estimation of risk factors for admission to intensive care units and for death in patients infected with A (H1N1) 2009 influenza virus, France, 2009–2010. PLoS Curr. 2010; 2: RRN1150.

8. Nguyen5Van5Tam J. S., Openshaw P. J.M., Hashim A. et al. Risk factors for hospitalization and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May–September 2009). Thorax 2010; 65 (7): 645–651.

9. Rello J., Rodriguez A., Ibanez P. et al. Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain. Crit. Care 2009; 13 (5): R148.

10. Kim H.S., Kim J.H., Shin S.Y. et al. Fatal Cases of 2009 Pandemic Influenza A (H1N1) in Korea. J. Korean Med. Sci. 2011; 26 (1): 22–27.

11. Черняев А.Л., Зайратьянц О.В., Полянко Н.И. и др. Патологическая анатомия гриппа А/H1N1. Арх. пат. 2010; 3: 3–6.

12. Ma J., Strub P., Camargo C. A. et al. The Breathe Easier through Weight Loss Lifestyle (BE WELL) Intervention: A randomized controlled trial. BMC Pulm. Med. 2010; 10: 16.

13. Medoff B.D., Okamoto Y., Leyton P. et al. Adiponectin Deficiency Increases Allergic Airway Inflammation and Pulmonary Vascular Remodeling. Am. J. Respir. Cell Mol. Biol. 2009; 41 (4): 397–406.

14. Гришкевич Н.Ю., Манчук В.Т., Савченко А.А. Особенности состояния клеточного и гуморального иммунитета у детей с различными формами ожирения. Педиатрия 2005; 3: 25–29.

15. Smith A.G., Sheridan P.A., Tseng R.J. et al. Selective impairment in dendritic cell function and altered antigen-specific CD8+ T-cell responses in diet-induced obese mice infected with influenza virus. Immunology 2009; 126 (2): 268–279.

16. Boumat J.C., Brown C.W. Mitochondrial dysfunction in obesity. Curr. Opin. Endocrinol. Diabet. Obes. 2010; 17 (5): 446–452.

17. Munger J., Bennett B.D., Parikh A. et al. Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat. Biotechnol. 2008; 26 (10): 1179–1186.

18. Chen C.J., Chen G.W., Wang C.H. et al. Differential localization and function of PB1-F2 derived from different strains of influenza A virus. J. Virol. 2010; 84 (19): 10051–10062.